MINIMS PHENYLEPHRINE HYDROCHLORIDE SOLUTION

Nchi: Kanada

Lugha: Kiingereza

Chanzo: Health Canada

Viambatanisho vya kazi:

PHENYLEPHRINE HYDROCHLORIDE

Inapatikana kutoka:

BAUSCH & LOMB INC

ATC kanuni:

S01FB01

INN (Jina la Kimataifa):

PHENYLEPHRINE

Kipimo:

10%

Dawa fomu:

SOLUTION

Tungo:

PHENYLEPHRINE HYDROCHLORIDE 10%

Njia ya uendeshaji:

OPHTHALMIC

Vitengo katika mfuko:

15G/50G

Dawa ya aina:

Prescription

Eneo la matibabu:

MYDRIATICS

Bidhaa muhtasari:

Active ingredient group (AIG) number: 0100662005; AHFS:

Idhini hali ya:

APPROVED

Idhini ya tarehe:

2020-12-03

Tabia za bidhaa

Bausch Health, Canada Inc.
MINIMS PHENYLEPHRINE HYDROCHLORIDE
_RA Last revised: December 1, 2020 (CYP) _
ENGLISH
FRENCH
MINIMS
 PHENYLEPHRINE
HYDROCHLORIDE 2.5 %
Phenylephrine Hydrochloride Ophthalmic Solution
PR
MINIMS
 PHENYLEPHRINE
HYDROCHLORIDE 10 %
Phenylephrine Hydrochloride Ophthalmic Solution
PRESCRIBING INFORMATION
MINIMS
MD CHLORHYDRATE DE
PHENYLEPHRINE 2.5 %
Solution ophthalmique de chlorhydrate de phényléphrine
PR
MINIMS
MD CHLORHYDRATE DE
PHENYLEPHRINE 10 %
Solution ophthalmique de chlorhydrate de phényléphrine
RENSEIGNEMENTS POSOLOGIQUES
PRESENTATION
Single dose clear, colourless, sterile eye drops. Two strengths
are available: Phenylephrine Hydrochloride BP 2.5% and 10%
w/v solutions, containing stabilizing agents: EDTA 0.05 w/v,
Sodium Metabisulfite 0.1 %, Purified Water.
USES
Phenylephrine is a directly acting sympathomimetic agent used
topically in the eye as a mydriatic. It may be indicated to dilate
the pupil in diagnostic or therapeutic procedures.
DOSAGE AND ADMINISTRATION
ADULTS
Apply one drop to each eye. If necessary, this dose may be
repeated once only, at least one hour after the first drop.
N.B. The use of a drop of topical anaesthetic a few minutes
before instillation of phenylephrine is recommended to prevent
stinging.
CHILDREN AND THE ELDERLY
The use of phenylephrine 10% solution is contraindicated in
these groups because of the increased risks of systemic toxicity.
Each Minims unit should be discarded after a single use.
CONTRANDICATIONS, WARNINGS ETC.
CONTRANDICATIONS
I.
Patients with cardiac disease, hypertension, aneurysms,
thyrotoxicosis, long-standing insulin-dependent
diabetes and tachycardia.
II.
Patients on monoamine oxidase inhibitors, tricyclic
antidepressants and anti-hypertensive agents (including
betablockers).
III.
Patients with closed angle glaucoma (unless previously
treated with iridectomy) and patients with a narrow
angle prone to glaucoma precipitated by mydriatics.
IV.
Hypersensitivity to phenylephrine or any component of
PRESENTATION
Collyres stérile